Lundbeck seems to have brought its migraine prevention drug bocunebart back on track, after dropping development of one formulation of the anti-PACAP antibody last year. Results from the phase 2b ...
A United States court has ordered that documents relating to the Duke of Sussex’s visa application must be made public by ...